Table 1. Patients’ characteristics at baseline.
| Control group (n = 26) | Pioglitazone group (n = 22) | P‐value | |
|---|---|---|---|
| Age (years) | 57.2 ± 11.3 | 56.0 ± 9.7 | 0.70 |
| n, Sex (female/male) | 8/18 | 4/18 | 0.37 |
| Height (cm) | 164.0 ± 8.4 | 165.5 ± 9.0 | 0.53 |
| Weight (kg) | 73.4 ± 15.4 | 70.5 ± 11.0 | 0.47 |
| Body mass index (kg/m2) | 26.9 ± 4.4 | 25.5 ± 3.1 | 0.21 |
| Duration of diabetes (year) | 14.8 ± 7.2 | 13.4 ± 7.4 | 0.51 |
| Blood pressure | |||
| Systolic (mmHg) | 133.1 ± 13.7 | 123.2 ± 13.0 | 0.02 |
| Diastolic (mmHg) | 78.3 ± 11.1 | 75.4 ± 10.3 | 0.40 |
| HbA1c (%) | 8.64 ± 1.23 | 8.59 ± 1.28 | 0.58 |
| Total daily insulin dose (U) | 39.6 ± 14.5 | 37.2 ± 20.4 | 0.39 |
| Total daily insulin dose (U/day/kg) | 0.57 ± 0.26 | 0.54 ± 0.31 | 0.26 |
| Times of insulin injection (/day) | 3.4 ± 0.8 | 3.1 ± 0.6 | 0.24 |